Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
International Journal of Dermatology
|
January 20, 2011
Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
Yevgeniy Balagula, Claus Garbe, Patricia L Myskowski, et al.
American Journal of Clinical Dermatology
|
April 30, 2013
Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic
Alyx C Rosen, Emily C Case, Stephen W Dusza, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
November 19, 2011
Dermoscopic features of basal cell carcinomas: differences in appearance under non-polarized and polarized light
Tracey N Liebman, Natalia Jaimes-Lopez, Yevgeniy Balagula, et al.
Journal of Cutaneous Pathology
|
October 27, 2018
Cryptococcus-like changes in the setting of vasculitis
Amber Fresco, Jenny Wang, Aimee Krausz, et al.
Journal of the American Academy of Dermatology
|
October 28, 2011
The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions
Yevgeniy Balagula, Ralph P Braun, Harold S Rabinovitz, et al.
Pediatric Dermatology
|
July 6, 2021
Heterogeneous cutaneous findings associated with intrauterine HSV infection: A case series and literature review
Deeti J Pithadia, Michelle L Kerns, William C Golden, et al.
Anti-Cancer Drugs
|
October 11, 2013
Life-threatening dermatologic adverse events in oncology
Alyx C Rosen, Yevgeniy Balagula, Dennis W Raisch, et al.
Cancer
|
March 23, 2012
Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors
Yevgeniy Balagula, Alyx Rosen, Belinda H Tan, et al.
JAAD Case Reports
|
August 19, 2021
Mitomycin extravasation injury: A case series
Karolina Mieczkowska, Alana Deutsch, Bijal Amin, et al.
JAAD International
|
February 3, 2026
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP)
Kristina Callis Duffin, Christopher E M Griffiths, Matthias Hoffmann, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
International Journal of Dermatology
|
January 20, 2011
Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
Yevgeniy Balagula, Claus Garbe, Patricia L Myskowski, et al.
American Journal of Clinical Dermatology
|
April 30, 2013
Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic
Alyx C Rosen, Emily C Case, Stephen W Dusza, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
November 19, 2011
Dermoscopic features of basal cell carcinomas: differences in appearance under non-polarized and polarized light
Tracey N Liebman, Natalia Jaimes-Lopez, Yevgeniy Balagula, et al.
Journal of Cutaneous Pathology
|
October 27, 2018
Cryptococcus-like changes in the setting of vasculitis
Amber Fresco, Jenny Wang, Aimee Krausz, et al.
Journal of the American Academy of Dermatology
|
October 28, 2011
The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions
Yevgeniy Balagula, Ralph P Braun, Harold S Rabinovitz, et al.
Pediatric Dermatology
|
July 6, 2021
Heterogeneous cutaneous findings associated with intrauterine HSV infection: A case series and literature review
Deeti J Pithadia, Michelle L Kerns, William C Golden, et al.
Anti-Cancer Drugs
|
October 11, 2013
Life-threatening dermatologic adverse events in oncology
Alyx C Rosen, Yevgeniy Balagula, Dennis W Raisch, et al.
Cancer
|
March 23, 2012
Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors
Yevgeniy Balagula, Alyx Rosen, Belinda H Tan, et al.
JAAD Case Reports
|
August 19, 2021
Mitomycin extravasation injury: A case series
Karolina Mieczkowska, Alana Deutsch, Bijal Amin, et al.
JAAD International
|
February 3, 2026
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP)
Kristina Callis Duffin, Christopher E M Griffiths, Matthias Hoffmann, et al.
Page
of 6